Orno (8Mg) 2Ml Vial Injection

Overview

Orno (8mg) 2ml Vial Injection is a prescription injectable medicine containing lornoxicam 8mg. Lornoxicam is a non-steroidal anti-inflammatory drug (NSAID) from the oxicam group, used when a clinician considers injectable pain and inflammation control appropriate. This product is supplied as a single vial for professional administration and should not be self-injected.

Because this is an injectable NSAID, it is intended for supervised use in patients who have been assessed for pain severity, bleeding risk, stomach ulcer history, kidney and liver function, cardiovascular risk, allergy history and other medicines being taken. The dose, interval and duration should always be decided by a registered healthcare professional.

Benefits

• Helps reduce pain by inhibiting inflammatory prostaglandin pathways
• May help reduce inflammation-related swelling and stiffness
• Injectable route supports supervised clinical use when oral dosing is unsuitable or not preferred

Key Features

• Contains lornoxicam 8mg in a 2ml vial presentation
• Prescription NSAID analgesic and anti-inflammatory injection
• Designed for intramuscular or intravenous administration by trained healthcare staff
• Pack size: 1 vial
• Manufacturer listed as Sami Pharmaceuticals

Dosage and How to Use

• How to use: For professional administration only. The healthcare professional should inspect the vial, prepare it according to the product pack or clinical protocol, and administer it by the prescribed intramuscular or intravenous route.
• Administration: Intramuscular or intravenous administration by a trained healthcare professional after appropriate preparation and inspection of the vial.
• Recommended dose: Use exactly as prescribed. Common adult prescribing information for lornoxicam injection lists 8mg by intravenous or intramuscular route, with dose and frequency individualized by the prescriber.
• Adult dose: Typical adult injectable dosing is 8mg IV or IM as prescribed; total daily dose and treatment duration must be determined by the clinician.
• Pediatric use: Do not use in children or adolescents unless specifically prescribed by a specialist; pediatric dosing and safety must be clinically assessed.
• Elderly use: Use with caution in elderly patients because gastrointestinal, kidney and cardiovascular adverse effects may be less well tolerated; renal or hepatic impairment may require dose review.
• When to take: Use only at the time and interval prescribed by the doctor for the treated pain or inflammatory condition.
• With food: Food timing is not directly applicable to an injection. The prescriber may still consider gastrointestinal protection or meal timing for overall NSAID tolerance.
• Maximum daily dose: Product information for lornoxicam injection commonly states that the daily dose should not exceed 16mg; some patients may require additional supervised dosing during the first 24 hours only if the prescriber directs it.
• Missed dose: Because this injection is usually administered by healthcare staff, contact the doctor, clinic or pharmacist if a scheduled dose is missed. Do not double the next dose.
• Overdose: Seek urgent medical help or contact the nearest emergency service if overdose is suspected. Symptoms may include severe stomach pain, vomiting, bleeding, dizziness, drowsiness, kidney problems or breathing difficulty.

Specifications

Side Effects

Common side effects

• Nausea
• Indigestion
• Abdominal pain
• Diarrhoea
• Headache
• Dizziness
• Injection-site discomfort
• Skin rash

Serious side effects (seek medical help)

• Gastrointestinal bleeding or ulceration
• Severe allergic reaction or bronchospasm
• Severe skin reaction
• Kidney injury or reduced urination
• Liver injury or jaundice
• Fluid retention or worsening heart failure
• Chest pain or stroke-like symptoms
• Unusual bruising or bleeding

Allergic reaction

Avoid use and seek urgent medical help if you develop wheezing, facial swelling, hives, severe rash, throat tightness or difficulty breathing after NSAID exposure.

Safety and Precautions

• Prescription-only medicine; use only under medical supervision
• NSAIDs can cause stomach ulceration, gastrointestinal bleeding, kidney problems and cardiovascular complications in susceptible patients
• Do not combine with other NSAIDs unless specifically directed by a doctor
• Stop and seek urgent care if allergic reaction, breathing difficulty, black stools, vomiting blood, chest pain or severe skin reaction occurs
• Inform the doctor about all current medicines and supplements before use
• Use the lowest effective dose for the shortest duration advised by the prescriber
• Use cautiously in patients with a history of ulcers, bleeding disorders, asthma, high blood pressure, heart disease, kidney disease, liver disease or inflammatory bowel disease
• Monitor for stomach pain, bleeding symptoms, reduced urination, swelling, dizziness or rash

When not to use

Known hypersensitivity to lornoxicam or any component of the injection | History of asthma, urticaria, angioedema or allergic reaction triggered by aspirin or other NSAIDs | Active or recurrent peptic ulcer or gastrointestinal bleeding | Severe heart failure | Severe kidney impairment | Severe liver impairment | Thrombocytopenia or significant bleeding disorder | Third trimester of pregnancy

Special populations

• Pregnancy: Do not use in the third trimester of pregnancy. Earlier pregnancy use should be avoided unless a doctor decides it is clearly necessary.
• Breastfeeding: Not recommended during breastfeeding unless a doctor specifically advises use after assessing the potential risks and benefits.
• Fertility: NSAIDs may impair female fertility temporarily; patients trying to conceive should discuss alternatives with a healthcare professional.
• Liver: Use with caution in liver impairment and avoid in severe liver disease unless a specialist determines otherwise; seek help if jaundice, dark urine or severe fatigue develops.
• Kidney: Use with caution in kidney impairment, dehydration, elderly patients or those using diuretics, ACE inhibitors or ARBs; avoid in severe renal impairment unless directed by a specialist.
• Heart: NSAIDs may worsen fluid retention, blood pressure control or heart failure and may increase cardiovascular risk in susceptible patients; use only after medical assessment.
• Driving: May cause dizziness, drowsiness or visual disturbance. Avoid driving or operating machinery if affected.
• Alcohol: Avoid or limit alcohol because it can increase the risk of stomach irritation and gastrointestinal bleeding with NSAIDs.

Interactions

Drugs:

• Other NSAIDs or high-dose aspirin
• Anticoagulants such as warfarin
• Antiplatelet medicines such as clopidogrel
• Corticosteroids
• Selective serotonin reuptake inhibitors
• ACE inhibitors, ARBs and diuretics
• Lithium
• Methotrexate
• Ciclosporin or tacrolimus
• Digoxin
• CYP2C9 inhibitors or inducers when clinically relevant

Food:

• No specific food interaction is established for the injection route
• alcohol should be avoided or limited due to increased gastrointestinal bleeding risk.

Conditions:

• Peptic ulcer disease or gastrointestinal bleeding
• NSAID-sensitive asthma or allergy
• Kidney impairment
• Liver impairment
• Heart failure or uncontrolled hypertension
• Bleeding disorders or thrombocytopenia
• Inflammatory bowel disease
• Recent major surgery or dehydration

Storage and Disposal

• Store according to the product label and pharmacist's instructions, in the original packaging, away from excessive heat, moisture and direct light.
• Keep out of the reach and sight of children.
• Dispose of used vials, ampoules, needles and syringes through appropriate clinical sharps or pharmaceutical waste channels. Do not reuse injection materials.

Disclaimer

This medicine information is for educational purposes only and is not a substitute for professional medical advice. Use only as prescribed by a qualified healthcare professional.